Apellis Pharmaceuticals I...

NASDAQ: APLS · Real-Time Price · USD
17.33
0.53 (3.15%)
At close: May 29, 2025, 3:32 PM
3.15%
Bid 17.32
Market Cap 2.18B
Revenue (ttm) 775.84M
Net Income (ttm) -223.68M
EPS (ttm) -1.8
PE Ratio (ttm) -9.63
Forward PE -28.57
Analyst Hold
Ask 17.34
Volume 1,051,283
Avg. Volume (20D) 2,517,247
Open 17.07
Previous Close 16.80
Day's Range 16.65 - 17.48
52-Week Range 16.10 - 43.76
Beta 0.72

About APLS

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol APLS
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for APLS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
3 weeks ago
-5.91%
Apellis Pharmaceuticals shares are trading lower a... Unlock content with Pro Subscription
1 month ago
+3.7%
Apellis Pharmaceuticals shares are trading higher after the company announced FDA acceptance, priority review of sNDA for EMPAVELI.